Scott E Kopetz Selected Research

Scott E Kopetz Research Topics

11	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 01/2017
11	Neoplasms (Cancer) 02/2024 - 10/2013
9	Neoplasm Metastasis (Metastasis) 01/2021 - 10/2013
2	Colonic Neoplasms (Colon Cancer) 01/2022 - 01/2018
2	Rectal Neoplasms (Rectal Cancer) 07/2017 - 02/2014
1	Adenocarcinoma 01/2022
1	Adenoma (Adenomas) 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Pathologic Complete Response 07/2017
1	Margins of Excision 01/2016

6	Biomarkers (Surrogate Marker)IBA 02/2024 - 01/2017
3	ErbB Receptors (EGF Receptor)IBA 05/2017 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 02/2024 - 01/2018
2	Bevacizumab (Avastin)FDA Link 12/2020 - 02/2014
1	adagrasibIBA 04/2024
1	Cetuximab (Erbitux)FDA Link 04/2024
1	histone H3 trimethyl Lys4IBA 01/2022
1	sotorasibIBA 01/2022
1	DT2216IBA 01/2022
1	snake venom protein C activatorIBA 01/2022
1	Proteolysis Targeting ChimeraIBA 01/2022
1	ChromatinIBA 01/2022
1	HeterochromatinIBA 01/2022
1	Histones (Histone)IBA 01/2022
1	Annexin A5IBA 01/2022
1	Smad Proteins (Mothers Against Decapentaplegic Homolog)IBA 01/2018
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2018
1	Fluorouracil (Carac)FDA LinkGeneric 07/2017
1	Calcibiotic Root Canal SealerIBA 05/2017
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 02/2014
1	Capecitabine (Xeloda)FDA Link 02/2014